These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
325 related items for PubMed ID: 11408544
1. Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists. Gao Z, Li Z, Baker SP, Lasley RD, Meyer S, Elzein E, Palle V, Zablocki JA, Blackburn B, Belardinelli L. J Pharmacol Exp Ther; 2001 Jul; 298(1):209-18. PubMed ID: 11408544 [Abstract] [Full Text] [Related]
2. 2-substituted pi system derivatives of adenosine that are coronary vasodilators acting via the A2A adenosine receptor. Zablocki J, Palle V, Blackburn B, Elzein E, Nudelman G, Gothe S, Gao Z, Li Z, Meyer S, Belardinelli L. Nucleosides Nucleotides Nucleic Acids; 2001 Jul; 20(4-7):343-60. PubMed ID: 11563047 [Abstract] [Full Text] [Related]
3. Comparative profile of vasodilation by CVT-3146, a novel A2A receptor agonist, and adenosine in conscious dogs. Zhao G, Linke A, Xu X, Ochoa M, Belloni F, Belardinelli L, Hintze TH. J Pharmacol Exp Ther; 2003 Oct; 307(1):182-9. PubMed ID: 12954805 [Abstract] [Full Text] [Related]
4. Prolonged exposure to 5'-N-ethylcarboxamidoadenosine (NECA) does not affect the adenosine A2A-mediated vasodilation in porcine coronary arteries. Conti A, Lozza G, Monopoli A. Pharmacol Res; 1997 Feb; 35(2):123-8. PubMed ID: 9175581 [Abstract] [Full Text] [Related]
5. A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea-pig. Snowdy S, Liang HX, Blackburn B, Lum R, Nelson M, Wang L, Pfister J, Sharma BP, Wolff A, Belardinelli L. Br J Pharmacol; 1999 Jan; 126(1):137-46. PubMed ID: 10051130 [Abstract] [Full Text] [Related]
6. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells. Chern Y, Lai HL, Fong JC, Liang Y. Mol Pharmacol; 1993 Nov; 44(5):950-8. PubMed ID: 8246918 [Abstract] [Full Text] [Related]
7. A2A-adenosine receptor reserve for coronary vasodilation. Shryock JC, Snowdy S, Baraldi PG, Cacciari B, Spalluto G, Monopoli A, Ongini E, Baker SP, Belardinelli L. Circulation; 1998 Aug 18; 98(7):711-8. PubMed ID: 9715864 [Abstract] [Full Text] [Related]
8. Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine. Hein TW, Wang W, Zoghi B, Muthuchamy M, Kuo L. J Mol Cell Cardiol; 2001 Feb 18; 33(2):271-82. PubMed ID: 11162132 [Abstract] [Full Text] [Related]
9. Mechanisms involved in increased sensitivity to adenosine A(2A) receptor activation and hypoxia-induced vasodilatation in porcine coronary arteries. Hedegaard ER, Nielsen BD, Mogensen S, Rembold CM, Frøbert O, Simonsen U. Eur J Pharmacol; 2014 Jan 15; 723():216-26. PubMed ID: 24309216 [Abstract] [Full Text] [Related]
10. Adenosine A(2A) receptors mediate coronary microvascular dilation to adenosine: role of nitric oxide and ATP-sensitive potassium channels. Hein TW, Belardinelli L, Kuo L. J Pharmacol Exp Ther; 1999 Nov 15; 291(2):655-64. PubMed ID: 10525085 [Abstract] [Full Text] [Related]
11. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes. Sun WC, Moore JN, Hurley DJ, Vandenplas ML, Linden J, Cao Z, Murray TF. Vet Immunol Immunopathol; 2008 Jan 15; 121(1-2):91-100. PubMed ID: 17913243 [Abstract] [Full Text] [Related]
12. A novel mechanism of vasoregulation: ADP-induced relaxation of the porcine isolated coronary artery is mediated via adenosine release. Rayment SJ, Ralevic V, Barrett DA, Cordell R, Alexander SP. FASEB J; 2007 Feb 15; 21(2):577-85. PubMed ID: 17167068 [Abstract] [Full Text] [Related]
13. Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists. Baraldi PG, Cacciari B, Spalluto G, Bergonzoni M, Dionisotti S, Ongini E, Varani K, Borea PA. J Med Chem; 1998 Jun 04; 41(12):2126-33. PubMed ID: 9622554 [Abstract] [Full Text] [Related]
14. Selective A2A adenosine receptor agonist as a coronary vasodilator in conscious dogs: potential for use in myocardial perfusion imaging. Trochu JN, Zhao G, Post H, Xu X, Belardinelli L, Belloni FL, Hintze TH. J Cardiovasc Pharmacol; 2003 Jan 04; 41(1):132-9. PubMed ID: 12500031 [Abstract] [Full Text] [Related]
15. Role of K+ channels in A2A adenosine receptor-mediated dilation of the pressurized renal arcuate artery. Prior HM, Yates MS, Beech DJ. Br J Pharmacol; 1999 Jan 04; 126(2):494-500. PubMed ID: 10077243 [Abstract] [Full Text] [Related]
16. The future of pharmacologic stress: selective A2A adenosine receptor agonists. Cerqueira MD. Am J Cardiol; 2004 Jul 22; 94(2A):33D-40D; discussion 40D-42D. PubMed ID: 15261132 [Abstract] [Full Text] [Related]
17. ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus. Cunha RA, Constantino MD, Ribeiro JA. Br J Pharmacol; 1997 Dec 22; 122(7):1279-84. PubMed ID: 9421273 [Abstract] [Full Text] [Related]
18. The A2A adenosine receptor mediates coronary vasodilation. Belardinelli L, Shryock JC, Snowdy S, Zhang Y, Monopoli A, Lozza G, Ongini E, Olsson RA, Dennis DM. J Pharmacol Exp Ther; 1998 Mar 22; 284(3):1066-73. PubMed ID: 9495868 [Abstract] [Full Text] [Related]
19. Antagonism of coronary artery relaxation by adenosine A2A-receptor antagonist ZM241385. Arif Hasan AZ, Abebe W, Mustafa SJ. J Cardiovasc Pharmacol; 2000 Feb 22; 35(2):322-5. PubMed ID: 10672868 [Abstract] [Full Text] [Related]
20. Adenosine receptor subtypes and vasodilatation in rat skeletal muscle during systemic hypoxia: a role for A1 receptors. Bryan PT, Marshall JM. J Physiol; 1999 Jan 01; 514 ( Pt 1)(Pt 1):151-62. PubMed ID: 9831723 [Abstract] [Full Text] [Related] Page: [Next] [New Search]